80021908: 18th Annual Lipid Disorders Training Center: Basic Program

Click here for a text version of the brochure
Text version of brochure

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 15.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
NURSING CREDIT
ANCC
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This 15.2 contact hour Educational Activity is provided by The Institute for Johns Hopkins Nursing.
AANP (Pending Approval)
The Institute for Johns Hopkins Nursing is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners: AANP Provider Number 061216.
Pharmacology hours are pending.
OTHER CREDIT
AAFP Pending
Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
American Academy of Physician Assistants (AAPA)
AAPA accepts AMA Category 1 CME credit for the PRA from organizations accredited by ACCME.

Description:
Cardiovascular disease remains the number one cause of death in the United States for 2009. Diabetes mellitus, high blood cholesterol and other lipids, high blood pressure, metabolic syndrome, overweight and obesity and physical inactivity remain atop the risk factors for cardiovascular disease.
Due to disease prevalence, there is a constant influx of new or modified drugs, novel risk factors to understand and improved laboratory tests to interpret in the area of dyslipidemia and cardiovascular disease. Even with constant advances in the field, the fundamental basis of inherited lipid diseases is often misunderstood.
Utilizing didactic lecture, case presentations and workshops, this two-day course will provide the practical science necessary to operate a lipid clinic. Disease states from pathophysiology to clinical care and multiple therapeutic options for combating them will be explored. Combination therapeutics, including pharmacotherapy, diet and exercise, are presented for multiple scenarios.

Objectives:
After attending this activity, the participant will demonstrate the ability to:
• Identify abnormal lipid lab results and apply latest diagnostic tests
• Utilize the latest information on the efficacy and side effects of lipid-altering drugs
• Manage the most difficult cases of dyslipidemia
• Apply information from review of pathways of lipid metabolism

Statement of Need:
Cardiovascular disease remains the number one cause of death in the United States for 2009. Diabetes mellitus, high blood cholesterol and other lipids, high blood pressure, metabolic syndrome, overweight and obesity and physician inactivity remain atop the risk factors for cardiovascular disease.
Due to disease prevalence, there is a constant influx of new or modified drugs, novel risk factors to understand and improved laboratory tests to interpret in the area of dyslipidemia nad cardiovascular disease. Even with constant advances in the field, the fundamental basis of inherited lipid diseases is often misunderstood.
Through didactic lecture, case presentations and workshops, this two-day course will provide the practical science necessary to operate a lipid clinic. Disease states from pathophysiology to clinical care and multiple therapeutic options for combating them will be explored. Combination therapeutics, including pharmacotherapy, diet and exercise, etc. are presented for multiple scenarios.

Talks

Policy On Speaker And Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.